Who pays for failed organ procurement and what is the cost of altruism ?
Annual Meeting of the American Society of Transplant Physicians. Dallas, Texas (USA), 1996/05/26.
Our objective was to define medical complications and financial charges generated during the care of potential solid organ donors who fail to donate after consent has been obtained.
A retrospective review of financial and medical records of potential organ donors was done at an urban level 1 trauma center.
Total hospital stay (T1+T2) for the group was broken down into the interval between admission and diagnosis of lethality (T1) and between diagnosis of lethality and death (T2).
Medical complications occurring during the hospital stay and charges generated during each time interval were abstracted.
After consent was obtained, 19 of 53 (36%) potential donors failed to donate : 9 of 19 (47%) expired prior to legal determination of brain death ; 10 patients failed to progress to brain death and were made DNR.
Of these, 9 died within 24 hr, 1 survived 16 days ; 6 of the 10 patients did not meet brain death criteria, and 4 were rejected by the OPO for reasons of infectious risks.
There were 3.1±1.3 medical complications per patient.
T1 was less than 4 hr in 16/19 (84%) potential donors and constituted a small percentage of the mean total hospital stay (37±10 hr).
Charges generated during T1+T2 (33,997±25,843) and specifically during T2 (17,385±9453) were considerable.
These charges were passed on to patients'families or third party payers though care was directed solely at organ procurement after diagnosis of lethality. (...)
Mots-clés Pascal : Don organe, Homme, Economie santé, Coût
Mots-clés Pascal anglais : Organ donation, Human, Health economy, Costs
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0171576
Code Inist : 002B27C. Création : 21/05/1997.